Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Monireh Torabi-Rahvar"'
Autor:
Sasan Ghaffari, Monireh Torabi-Rahvar, Sajjad Aghayan, Zahra Jabbarpour, Kobra Moradzadeh, Azadeh Omidkhoda, Naser Ahmadbeigi
Publikováno v:
BMC Immunology, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background The successful ex vivo expansion of T-cells in great numbers is the cornerstone of adoptive cell therapy. We aimed to achieve the most optimal T-cell expansion condition by comparing the expansion of T-cells at various seeding den
Externí odkaz:
https://doaj.org/article/fd272219f60d4a70b57f0aa99135ac09
Autor:
Mahya Dezfouli, Sofia Bergström, Lillemor Skattum, Hassan Abolhassani, Maja Neiman, Monireh Torabi-Rahvar, Clara Franco Jarava, Andrea Martin-Nalda, Juana M. Ferrer Balaguer, Charlotte A. Slade, Anja Roos, Luis M. Fernandez Pereira, Margarita López-Trascasa, Luis I. Gonzalez-Granado, Luis M. Allende-Martinez, Yumi Mizuno, Yusuke Yoshida, Vanda Friman, Åsa Lundgren, Asghar Aghamohammadi, Nima Rezaei, Manuel Hernández-Gonzalez, Ulrika von Döbeln, Lennart Truedsson, Toshiro Hara, Shigeaki Nonoyama, Jochen M. Schwenk, Peter Nilsson, Lennart Hammarström
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The clinical outcomes of primary immunodeficiencies (PIDs) are greatly improved by accurate diagnosis early in life. However, it is not common to consider PIDs before the manifestation of severe clinical symptoms. Including PIDs in the nation-wide ne
Externí odkaz:
https://doaj.org/article/f39438c83a124a7b99700d19394fcd89
Autor:
Samad Muhammadnejad, Seyed Mostafa Monzavi, Monireh Torabi-Rahvar, Masoud Sotoudeh, Ahad Muhammadnejad, Sahar Tavakoli-Shiraji, Azam Ranjbar, Seyed Sajjad Aghayan, Amir Arsalan Khorsand, Kobra Moradzadeh, Ehsan Janzamin, Naser Ahmadbeigi
Publikováno v:
International immunopharmacology. 114
A preclinical study was designed to evaluate the effects of adoptively transferred cytokine-induced killer (CIK) cells on colorectal adenocarcinoma.Forty NOG mice bearing HT-29 xenograft tumors were developed and equally divided into 2 groups of trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecfb9c246a902191b01a1eb5ee6f9927
https://pubmed.ncbi.nlm.nih.gov/36463696
https://pubmed.ncbi.nlm.nih.gov/36463696
Publikováno v:
The International Journal of Artificial Organs. 44:727-733
Background: Sufficient blood vessel formation in bioengineered tissues is essential in order to keep the viability of the organs. Impaired development of blood vasculatures results in failure of the implanted tissue. The cellular source which is seed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d1a5aea1621261a10dad9620cd09a02
https://doi.org/10.1177/03913988211025538
https://doi.org/10.1177/03913988211025538
Autor:
Monireh Torabi-Rahvar
Publikováno v:
Current Pharmaceutical Design. 27:1549-1552
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02326cc30c4138d5c2f94cd20a0de419
https://doi.org/10.2174/18734286mtexfode32
https://doi.org/10.2174/18734286mtexfode32
Autor:
Faezeh Maghsood, Mohammad-Reza Shokri, Mahmood Jeddi-Tehrani, Monireh Torabi Rahvar, Abbas Ghaderi, Vahid Salimi, Gholam Ali Kardar, Amir-Hassan Zarnani, Mohammad Mehdi Amiri, Fazel Shokri
Publikováno v:
Pathogens and Disease
Given the emergence of SARS-CoV-2 virus as a life-threatening pandemic, identification of immunodominant epitopes of the viral structural proteins, particularly the nucleocapsid (NP) protein and receptor-binding domain (RBD) of spike protein, is impo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a9c0d4733da05ed2784d630b8c0358f
https://pubmed.ncbi.nlm.nih.gov/34994386
https://pubmed.ncbi.nlm.nih.gov/34994386
Publikováno v:
APMIS. 127:737-745
Currently, adoptive immunotherapy is considered as one of the leading treatments in cancer. Successful adoptive immunotherapy depends on producing large numbers of desired T cells ex vivo for infusion. This requires an effective protocol for maximum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::141708adf483ed8bc703a4776fed7de3
https://doi.org/10.1111/apm.12981
https://doi.org/10.1111/apm.12981
Autor:
Monireh Torabi-Rahvar, Nima Rezaei
Publikováno v:
Current pharmaceutical design. 27(13)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may lead to severe disease in some cases, leading to acute respiratory distress syndrome, multi-organ failure, and death. This severe phenotype seems to be associated with a cytokine storm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eba5c0f08aa27e10c30659802c56c65
https://pubmed.ncbi.nlm.nih.gov/33238863
https://pubmed.ncbi.nlm.nih.gov/33238863
Publikováno v:
Experimental Cell Research. 369:1-10
Chimeric antigen receptor (CAR) T cell therapy is anticipated to be increasingly implemented in the context of cancer treatment after two current FDA approval of anti-CD19 CAR-T cells (Kymriah™ & Yescarta™). The success of CD19 is mainly attribut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64eab9cee1f2eb77f9ddc9357ff25ef4
https://doi.org/10.1016/j.yexcr.2018.05.009
https://doi.org/10.1016/j.yexcr.2018.05.009
Publikováno v:
Journal of immunological methods. 477
Adoptive cell therapy (ACT) using tumor antigen-independent killer cells has been widely used in clinical trials of cancer treatment. Circumventing the need for identification of a particular tumor-associated antigen on tumor cells, the approach has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37b9ba143eb442751cdd5d9c5ae9ebb1
https://pubmed.ncbi.nlm.nih.gov/31678265
https://pubmed.ncbi.nlm.nih.gov/31678265